{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:23:39Z","timestamp":1789233819692,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jdiacomp.2026.109292","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:49:37Z","timestamp":1772005777000},"page":"109292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The long-term impact of early HbA1c control on nephropathy, neuropathy, and retinopathy in type 2 diabetes: Findings from a large UK observational study"],"prefix":"10.1016","volume":"40","author":[{"given":"Rami","family":"Aldafas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Vinogradova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.J.","family":"Crabtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskandar","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109292_bb0005","doi-asserted-by":"crossref","first-page":"e001847","DOI":"10.1136\/bmjdrc-2020-001847","article-title":"Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes","volume":"9","author":"An","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0010","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic targets: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00592-023-02037-8","article-title":"Long-term HbA1c variability and macro-\/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update","volume":"60","author":"Sartore","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-018-0787-8","article-title":"Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)","volume":"17","author":"Kosiborod","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group","volume":"329","author":"Shamoon","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","year":"1998","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0035","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004872-200106001-00004","volume":"19","year":"2001","journal-title":"J Hypertension"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0040","series-title":"Veterans Affairs diabetes trial\u2013corrections","first-page":"1024","author":"Moritz","year":"2009"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0045","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0050","series-title":"Diabetic Kidney Diseases Revisited: A New Perspective for a New Era","author":"Fu","year":"2019"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","article-title":"The general practice research database: role in pharmacovigilance","volume":"27","author":"Wood","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0065","series-title":"ICD-10 : international statistical classification of diseases and related health problems : tenth revision","author":"World Health Organisation","year":"2004"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0070","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0075","doi-asserted-by":"crossref","first-page":"e35285","DOI":"10.1097\/MD.0000000000035285","article-title":"Vascular complications of diabetes: a narrative review","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0080","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0085","series-title":"Akaike Information Criterion Statistics","first-page":"26853","volume":"81(10.5555)","author":"Sakamoto","year":"1986"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673976","article-title":"The risk threshold for hemoglobin A1c associated with albuminuria: a population-based study in China","volume":"12","author":"Lian","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/j.ajkd.2015.10.025","article-title":"Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study","volume":"67","author":"Melsom","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ypmed.2013.08.002","article-title":"Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany","volume":"57","author":"Sch\u00f6ttker","year":"2013","journal-title":"Prev Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0115","series-title":"The Handbook of Diabetes","author":"Williams","year":"2004"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/ijerph16050681","article-title":"Severe hypoglycemia as a predictor of end-stage renal disease in type 2 diabetes: a national cohort study","volume":"16","author":"Lee","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0125","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1097\/MD.0000000000000771","article-title":"Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study","volume":"94","author":"Shih","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0130","series-title":"Diabetic Nephropathy and Hypertension in Diabetes Patients of Sub-Saharan Countries: A Systematic Review and meta-Analysis","author":"Wagnew","year":"2018"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000381757","article-title":"The prevalence and management of diabetic nephropathy in Asia","volume":"1","author":"Tomino","year":"2015","journal-title":"Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0140","series-title":"The contribution of hypertension to diabetic nephropathy and retinopathy: The role of inflammation and oxidative stress","author":"De Faria","year":"2011"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0145","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00125-006-0297-1","article-title":"Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)","volume":"49","author":"Stratton","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","article-title":"Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy","volume":"285","author":"Mogensen","year":"1982","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","article-title":"Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy","volume":"321","author":"Parving","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0272-6386(12)70215-9","article-title":"Diabetic nephropathy in insulin-dependent patients","volume":"20","author":"Breyer","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2169\/internalmedicine.3242-19","article-title":"Effects of HbA1c on the development and progression of chronic kidney disease in elderly and middle-aged Japanese: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD)","volume":"59","author":"Yasuno","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3329\/kyamcj.v8i1.33868","article-title":"Prevalence of nephropathy with evaluation of HbA1c level and other associated risk factors in type 2 diabetic patients in a tertiary level hospital","volume":"8","author":"Hoque","year":"2017","journal-title":"KYAMC J"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnins.2019.00090","article-title":"HbA1c variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes","volume":"13","author":"Lai","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.2005.036137","article-title":"Diabetic neuropathy","volume":"82","author":"Bansal","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0185","series-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","author":"Hicks","year":"2019"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0190","first-page":"463","article-title":"Correlation between the severity of diabetic peripheral polyneuropathy and glycosylated hemoglobin levels: a quantitative study","volume":"40","author":"Lee","year":"2016","journal-title":"Ann Rehabil Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0195","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/dc08-0433","article-title":"The relationship of reduced peripheral nerve function and diabetes with physical performance in older white and black adults","volume":"31","author":"Strotmeyer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0200","first-page":"302","article-title":"Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control","volume":"7","author":"Nisar","year":"2015","journal-title":"Cureus"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0205","first-page":"1591","article-title":"Prevalence of lower-extremity disease in the US adult population \u226540 years of age with and without diabetes: 1999\u20132000 National Health and Nutrition Examination Survey","volume":"27","author":"Moneta","year":"2006","journal-title":"Yearb Vasc Surg"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0210","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2337\/diacare.17.10.1172","article-title":"Risk factors for distal symmetric neuropathy in NIDDM: the San Luis Valley diabetes study","volume":"17","author":"Franklin","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0215","series-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and. type. 2:diabetes","author":"Estacio","year":"2000"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"Group, U.K.P.D.S","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0230","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2337\/dc09-0554","article-title":"Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors","volume":"32","author":"Elliott","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0235","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.cpcardiol.2022.101581","article-title":"Hypertension the \u2018missed modifiable risk factor\u2019 for diabetic neuropathy: a systematic review","volume":"48","author":"Sethi","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0035-1550019","article-title":"The protective effect of losartan on diabetic neuropathy in a diabetic rat model","volume":"123","author":"Cavusoglu","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0245","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2015.08.015","article-title":"Effect of combination therapy consisting of enalapril, \u03b1-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat\/low dose streptozotocin treated rat","volume":"765","author":"Davidson","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0250","first-page":"355","article-title":"Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetics","volume":"51","author":"Kubba","year":"2003","journal-title":"Neurol India"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0255","article-title":"HbA1C, proliferative and non-proliferative retinopathy in diabetic patients","volume":"6","author":"Poshtchaman","year":"2023","journal-title":"Med Clin Pract"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2796.1998.00353.x","article-title":"The frequency and severity of retinopathy are related to HbA1c values after, but not at, the diagnosis of NIDDM","volume":"244","author":"Henricsson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339909787314176","article-title":"Metabolic control and diabetic retinopathy","volume":"5","author":"Rodriguez-Fontal","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0270","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjo.2009.169326","article-title":"Is age a risk factor for diabetic retinopathy?","volume":"94","author":"Tan","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0280","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol (Chicago, Ill.:1960)"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0285","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archopht.1994.01090210105023","article-title":"The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy","volume":"112","author":"Klein","year":"1994","journal-title":"Arch Ophthalmol (Chicago, Ill.:1960)"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0295","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0161-6420(97)30327-3","article-title":"Retinopathy and vision loss in insulin-dependent diabetes in Europe: the EURODIAB IDDM complications study","volume":"104","author":"Sjolie","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2026.109292_bb0300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000441958","article-title":"Antihypertensive drugs and diabetic retinopathy in patients with type 2 diabetes","volume":"235","author":"Lin","year":"2016","journal-title":"Ophthalmologica"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:34:03Z","timestamp":1775738043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1056872726000371"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109292","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term impact of early HbA1c control on nephropathy, neuropathy, and retinopathy in type 2 diabetes: Findings from a large UK observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109292"}}